Close

SCR Financial Facts

See Full Income Statement

See Full Balance Sheet

Simcere Pharmaceutical Group. (SCR) Earnings

  |   Expand Research on SCR
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate -23.8% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +2.6% Normal Earnings Time N/A
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
4/13/21 Q221 -Cdn$0.45N/A N/A Cdn$5.59MCdn$6.65M N/A Details
3/7/13 Q412 -$0.06$0.00 -$0.06$86.7M$88.06M N/A Details
11/11/10 Q310 $0.08N/A N/A N/AN/A N/A Details
7/13/21 Q321 -$0.78N/A N/A $6.1MN/A N/A Details
11/15/12 Q312 $0.07$0.07 $0.00$83.8M$85.72M N/A Details
3/7/12 Q411 $0.12$0.10 +$0.02$81.2M$86.35M N/A Details
8/10/12 Q212 $0.08$0.10 -$0.02$83.2M$86.83M N/A Details
5/9/12 Q112 $0.08$0.10 -$0.02$77.4M$84.31M N/A Details